{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T08:00:26Z","timestamp":1781251226534,"version":"3.54.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2026,6,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Hashimoto\u2019s thyroiditis [HT] is the most common autoimmune disease.\nInsulin resistance [IR], independent of thyroid function tests but attributed to thyroid autoantibodies,\ncan be observed in HT. The most frequently employed method for demonstrating IR is the\nHOMA-IR index. Recently, the triglyceride-glucose index [TGI] and triglyceride-to-HDL ratio [TG\/\nHDL] have been proposed as novel, practical, and cost-effective indicators of IR. Thus, this\nstudy aimed to investigate the relationship between TGI, TG\/HDL ratio, and HOMA-IR in euthyroid,\nnormoglycemic women aged 18\u201345 years with HT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective study was conducted at a tertiary care center and included 108 women\nwith HT and 62 healthy controls. Parameters recorded for all participants included TSH, free\nthyroxine [fT4], free triiodothyronine [fT3], anti-thyroglobulin antibody [anti-Tg], anti-thyroid\nperoxidase antibody [anti-TPO], glucose, triglycerides, HDL, LDL, insulin, HOMA-IR, TGI, and\nTG\/HDL ratio.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Compared to the healthy control group, TGI and TG\/HDL were significantly elevated in\npatients with HT, with respective values of 3.67 vs. 3.55 and 1.83 vs. 1.46 [p=0.001, p=0.005, respectively].\nAnti-TPO showed a weak positive correlation with HOMA-IR and moderate positive\ncorrelations with TGI and TG\/HDL [r=0.280, 0.352, and 0.336, respectively]. Similarly, anti-Tg\ncorrelated positively with HOMA-IR, TGI, and TG\/HDL [r=0.274, 0.187, and 0.159, respectively].\nA moderate, significant positive correlation was found between HOMAIR and both TGI and\nTG\/HDL [r=0.477 and 0.455, respectively]. Receiver operating characteristic analysis indicated\nthat TG\/HDL [area under the curve [AUC]: 0.802, 95% confidence interval [CI]: 0.716\u20130.888,\np&lt;0.001] and TGI [AUC: 0.824, 95% CI: 0.741\u20130.907, p&lt;0.001] had diagnostic value in predicting\nelevated HOMA-IR. Furthermore, a TG\/HDL ratio of \u22651.99 predicted elevated HOMA-IR\nwith 80.6% sensitivity and 70.1% specificity, while a TGI \u2265 3.68 had 87.1% sensitivity and 67.5%\nspecificity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Women with euthyroid, normoglycemic HT exhibit increased HOMA-IR. TGI and\nTG\/HDL are novel, cost-effective, accessible biomarkers that can be used to detect IR early in this\npatient group and facilitate screening across large populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118715303399805251024074458","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:32:47Z","timestamp":1781249567000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Triglyceride Glycemic Index and Triglyceride\/HDL Ratio: Can They be Biomarkers for Insulin Resistance in Euthyroid Women with Hashimoto's Thyroiditis, and Are They Related to Thyroid Function Tests?"],"prefix":"10.2174","volume":"26","author":[{"given":"Seher \u00c7etinkaya","family":"Altunta\u015f","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Bursa Yuksek Ihtisas Education and Training Hospital, University of Health Sciences, Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande","family":"\u00d6zgen","sequence":"additional","affiliation":[{"name":"Department of Public Health, Bursa Yuksek Ihtisas Education and Training Hospital, University of Health Sciences, Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715303399805251024074458","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/254927\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715303399805251024074458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:33:12Z","timestamp":1781249592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/254927\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715303399805251024074458","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-04-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}